跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 159 条关于
“Anhedonia”
全部
159
临床试验
135
药物
1
机构
1
资讯
22
9个月前
BioMed X and AbbVie Launch Neuroscience Collaboration to Target Anhedonia Mechanisms
去年
Epilepsy Drug Ezogabine Shows Promise as Novel Depression Treatment by Targeting Brain Potassium Channels
7个月前
LB Pharmaceuticals Launches Phase 2 Trial of LB-102 for Bipolar Depression Following Positive Schizophrenia Results
去年
Neumora's Depression Drug Navacaprant Fails Phase III Trial, Shares Plummet
去年
Johnson & Johnson Showcases Neuropsychiatry Innovations at Psych Congress
11天前
Johnson & Johnson to Present Phase 3 CAPLYTA Data Across Bipolar Mania, Depression and Schizophrenia at Psych Congress 2026
3个月前
Stanford Study: Ketamine-Buprenorphine Combination Sustains Anti-Suicidal Effects, Reviving the Opioid Hypothesis of Depression
去年
Neumora's Navacaprant Fails Phase 3 Trial for Major Depressive Disorder
10个月前
NetraMark's AI Platform Shows Promise in Precision Psychiatry with Enhanced Clinical Trial Design
8个月前
Johnson & Johnson Presents New Depression Treatment Data at ACNP 2026 Meeting
第 1 页,共 3 页
上一页
下一页